LOGOLOGOLOGOLOGO
    • About us
      • What we do
      • Who we are
        • Governance
        • Staff
        • Vacancies
    • Members
      • EuropaBio Members
      • About Membership
    • How we work
      • Healthcare Biotechnology Council
        • Patient BioForum
        • Study – Impact of the EU’s General Pharmaceutical Legislation
      • Industrial Biotechnology Council
        • EFIB
        • Microorganisms
      • National Associations Council
      • SME Platform
      • Biomanufacturing Platform
        • Biotechnology in our Lives
    • Activities
      • 25 Years of Innovation
      • The EU Biotech Act
      • European Biotech Week
      • EU Projects
        • PRIMED Project
        • APROVALS Project
    • News & Events
      • News
      • Events
    • Library
    Become a member
    ✕

    Marije Laffeber joins EuropaBio as Director of Industrial Biotechnology

    01/09/2026
    PRESS RELEASE

    Brussels, 1 September 2026 - EuropaBio is pleased to announce that Marije Laffeber has joined its senior leadership team as Director of Industrial Biotechnology. EuropaBio is the leading voice for biotechnology in Europe.

    Marije brings more than 25 years of experience at the intersection of politics, policy and business. She has held senior roles across European and international public affairs, working with political leaders, policymakers, Commissioners and MEPs on issues ranging from regulation and geopolitical strategy to risk management and stakeholder engagement.

    Her previous roles include Deputy Secretary General of the Party of European Socialists, International Secretary and Vice Chair for European Affairs of the Dutch Labour Party, Managing Director of Rud Pedersen Public Affairs Netherlands, and advisor to international democracy and governance programmes.

    Marije joins EuropaBio at a pivotal moment for European biotechnology, as innovative companies, world-class universities and research organisations work together to translate scientific excellence into industrial leadership, sustainable growth and strategic resilience for Europe.

    Dr Claire Skentelbery commented: “We are delighted that Marije has joined the team. Her political insights, experience and well-established leadership will help deliver biotechnology and biomanufacturing through legislation. This delivers on stated EU ambition and ensures that a competitive and sustainable Europe benefits all countries and citizens”.

    Marije added: "I am delighted to join EuropaBio at such an important moment for Europe. Biotechnology is a strategic tool to address some of our greatest challenges, from food security and climate change to sustainable growth and industrial competitiveness. By helping Europe move away from fossil resources, build a circular bioeconomy and create new industries, biotechnology can deliver solutions for both people and the planet. As the leading voice for biotechnology in Europe, EuropaBio is uniquely positioned to help turn innovation into impact, and I look forward to working with members and policymakers to unlock that potential."

    Marije Laffeber joins EuropaBio as Director of Industrial Biotechnology


    Download
    Share
    Adrian Lincoln

    Adrian Lincoln

    Related posts

    09/07/2026

    EuropaBio Position on targeted amendments of Directive 2001/18/EC: Unlocking the potential of genetically modified microbial products in Europe (July 2026)


    Read more
    06/07/2026

    EuropaBio Annual Report 2026


    Read more
    26/06/2026

    The European CRO Federation (EUCROF) joins EuropaBio: Advancing clinical research excellence in Europe


    Read more

    Important links

    • Marije Laffeber joins EuropaBio as Director of Industrial Biotechnology
    • Spain: Biotechnology in Security and Defence

    Categories in our Newsroom

    EBIO-white

    EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

    Contact us

    Extra links

    Members
    Staff
    Privacy policy
    Legal & cookies
    Events
    Newsroom

    Become a member

    Media pack

    © 2026 Europabio. All Rights Reserved. Designed by EYAS
    Become a member

    Vitamin B2

    The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

    Insulin

    Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

    Detergents

    Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

    Clothes

    Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

    Algal Omega 3

    Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

    Cheese

    Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.